News
3d
GlobalData on MSNBMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trialBMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...
5d
GlobalData on MSNBMS’ Opdivo combo approved in US for hepatocellular carcinomaThe US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in ...
Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...
Scottsbluff Public Schools will have 11 educators retiring after this school year. These individuals will be honored at a ...
According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...
Bench applauds baseball's efforts at BMS ...
18h
MedPage Today on MSNAppendectomy Reduced Relapse Rates in Ulcerative ColitisAppendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...
BMS urges Labour Minister to enhance ESI wage ceiling, stop contractual appointments, upgrade medical facilities for workers.
Following the success of the first-ever instalment of the Sarona Kalahari 1000 Race, the Botswana Motor Sport (BMS) is open to hosting more races of this magnitude.
Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of ...
The following personnel items are from the March 12 agenda of the Bettendorf Community School District. The School Board met ...
The result is a major disappointment for BMS as it effectively cuts the potential market for Camzyos in half. Sales of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results